Lead Product(s) : Fosamprenavir
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : ViiV Healthcare
Deal Size : Inapplicable
Deal Type : Inapplicable
HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 18, 2010
Lead Product(s) : Fosamprenavir
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : ViiV Healthcare
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
